Pregnancy and antibody to factor VIII

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Immunology

Background:

• Acquired factor VIII inhibitors can arise postpartum, posing risks during subsequent pregnancies.
• Management of pregnancy in women with coagulation inhibitors requires careful monitoring.

Observation:

• A patient developed a factor VIII antibody three weeks postpartum.
• She experienced spontaneous bruising in early pregnancy and a prolonged bleeding time with thrombocytopenia in the third trimester.

Findings:

• The factor VIII antibody became undetectable by the eighth month of gestation.
• Bleeding symptoms resolved during the second trimester of pregnancy.
• Platelet count normalized, and bleeding time returned to normal.

Implications:

• This case highlights the potential for spontaneous resolution of acquired factor VIII inhibitors during pregnancy.
• It underscores the importance of monitoring coagulation status in pregnant patients with a history of postpartum inhibitors.
• Further research into postpartum coagulation inhibitors is warranted.